- Home
- SYBT vs TLRY Comparison
SYBT vs TLRY Comparison
Compare SYBT & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SYBT | TLRY |
|---|---|---|
| Founded | 1904 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SYBT | TLRY |
|---|---|---|
| Price | $67.16 | $10.05 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $83.67 | ★ $150.00 |
| AVG Volume (30 Days) | 155.0K | ★ 20.0M |
| Earning Date | 01-21-2026 | 01-08-2026 |
| Dividend Yield | ★ 1.91% | N/A |
| EPS Growth | ★ 26.16 | N/A |
| EPS | ★ 4.58 | N/A |
| Revenue | $378,633,000.00 | ★ $830,766,000.00 |
| Revenue This Year | $17.26 | $7.28 |
| Revenue Next Year | $5.29 | $4.51 |
| P/E Ratio | $14.62 | ★ N/A |
| Revenue Growth | ★ 14.11 | 2.31 |
| 52 Week Low | $60.75 | $3.51 |
| 52 Week High | $83.83 | $23.20 |
Technical Indicators
Market Signals| Indicator | SYBT | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 48.02 | 61.70 |
| Support Level | $66.51 | $9.82 |
| Resistance Level | $69.09 | $15.70 |
| Average True Range (ATR) | 1.50 | 1.48 |
| MACD | -0.11 | -0.09 |
| Stochastic Oscillator | 22.75 | 34.61 |
Price Performance
Historical ComparisonAbout SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.